tom_murphy_sunlife

Tom Murphy Appointed President of Sun Life Asset Management Amid Strategic Global Integration

In a strategic realignment aimed at consolidating its global investment businesses, Sun Life Financial Inc. has named Tom Murphy as President of its newly unified asset management division, Sun Life Asset Management. The move is set to bring all of the company’s asset management operations under one umbrella for the first time. Murphy, a seasoned…

Read More

Strathcona Resources and Canada Growth Fund Forge $2 Billion Partnership for Carbon Capture Innovation

Strathcona Resources Ltd. (TSX: SCR) has announced a groundbreaking partnership with Canada Growth Fund (“CGF”), marking a significant leap forward in the realm of carbon capture and sequestration (CCS). Under this strategic agreement, CGF, a prominent $15 billion public investment vehicle, will inject up to $1 billion into CCS infrastructure across Strathcona’s steam-assisted gravity drainage…

Read More

e-Zinc Secures $31 Million to Pioneer Long-Duration Energy Storage Solutions

e-Zinc, a trailblazer in sustainable long-duration energy storage utilizing zinc-air battery technology, has announced the successful completion of a $31 million Series A2 funding round. Led by Evok Innovations and bolstered by investments from Mitsubishi Heavy Industries, Export Development Canada (EDC), and Ultratech Capital Partners, this funding will propel e-Zinc’s efforts in advancing commercialization initiatives….

Read More

Rock Tech Secures Up to 100 Million Euros in Grants for Revolutionary Lithium Refinery in Germany

Rock Tech Lithium Inc. (TSXV: RCK) (OTCQX: RCKTF) (FWB: RJIB) (WKN: A1XF0V) has announced a significant milestone in its mission to advance sustainable lithium production with the receipt of up to 100 million Euros in grants for its Lithium Converter project in Guben, Germany. The funding, to be provided by the State of Brandenburg and…

Read More

Valneva’s Breakthrough: Canada Approves World’s First Chikungunya Vaccine

Valneva SE has achieved a historic milestone with Health Canada’s approval of the world’s first chikungunya vaccine. Following its successful launch in the U.S. and pending European authorization, this decision underscores IXCHIQ®’s pivotal role in global healthcare strategy. Chikungunya, a mosquito-borne virus causing severe joint pain and fever, poses a significant public health threat with…

Read More

Ability Biologics Innovates AI-Driven Antibody Therapeutics with $18 Million Seed Funding Boost

Ability Biologics, a trailblazer in AI-driven therapeutic discovery, has closed an $18 million seed funding extension, marking a significant milestone in its quest to revolutionize antibody therapeutics for cancer and immune-related disorders. Led by founding investor Amplitude Ventures, this financing round includes strategic support from Fonds de solidarité FTQ, Investissement Québec, Charles River Laboratories, Theodorus,…

Read More